Rhythm PharmaceuticalsRYTM
那斯達克 · USD
97.60
-4.84
(-4.72%)
盤中 09/16 01:05 (UTC+8)
09/16 01:05 (UTC+8)
Rhythm PharmaceuticalsRYTM
97.60
-4.84
(-4.72%)
財務數據
損益表
- 0.26
- 0.29
- 0.33
- 0.42
- 0.33
- 0.49
- 0.51
- 0.57
- 0.60
- 0.71
- 7.15
- 11.98
- 14.35
- 25.80
- -21.82
- 48.31
- 5.76
- 11.61
- 4.99
- 18.54
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 71,255 | 60,112 | 57,253 | 51,298 | 48,502 | 32,704 | 41,830 | 33,251 | 29,078 | 25,967 |
營業成本 | 8,931 | 7,157 | 4,802 | 5,499 | 5,543 | 3,648 | 3,787 | 3,828 | 2,946 | 2,807 |
營業毛利 | 62,324 | 52,955 | 52,451 | 45,799 | 42,959 | 29,056 | 38,043 | 29,423 | 26,132 | 23,160 |
營業費用 | 110,876 | 105,316 | 99,514 | 98,452 | 88,255 | 76,060 | 79,298 | - | - | 163,047 |
研發費用 | 43,428 | 41,725 | 42,033 | 46,026 | 42,308 | 36,973 | 41,168 | 37,931 | 30,193 | 128,665 |
推銷及管理費用 | 67,448 | 63,591 | 57,481 | 52,426 | 45,947 | 39,087 | 38,130 | 35,377 | 36,415 | 34,382 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -48,552 | -52,361 | -47,063 | -52,653 | -45,296 | -47,004 | -41,255 | -43,885 | -40,476 | -139,887 |
其他收入及費用 | 4,238 | 1,850 | 4,142 | 4,602 | 4,818 | 2,995 | 3,320 | 5,663 | 13,297 | 3,570 |
利息費用 | 4,540 | 4,583 | 4,615 | 4,742 | 5,817 | 5,409 | 5,447 | 5,798 | 4,603 | 4,755 |
稅前純益 | -48,854 | -55,094 | -47,536 | -52,793 | -46,295 | -49,418 | -43,382 | -44,020 | -31,782 | -141,072 |
所得稅 | 444 | 545 | -31 | 111 | 337 | 80 | -90 | -343 | 479 | 300 |
稅後純益 | -49,298 | -55,639 | -47,505 | -52,904 | -46,632 | -49,498 | -43,292 | -43,677 | -32,261 | -141,372 |
基本每股稅後盈餘(元) | -0.73 | -0.83 | -0.73 | -0.82 | -0.75 | -0.81 | -0.72 | -0.73 | -0.55 | -2.35 |
稀釋每股稅後盈餘(元) | -0.74 | -0.83 | -0.73 | -0.82 | -0.75 | -0.81 | -0.72 | -0.73 | -0.54 | -2.35 |
基本平均股數(千股) | 68592.00 | 67974.00 | 66876.00 | 66261.00 | 63684.00 | 63059.00 | 61596.00 | 61219.00 | 61011.00 | 60143.00 |
稀釋平均股數(千股) | 68592.00 | 67974.00 | 66876.00 | 66261.00 | 63684.00 | 63059.00 | 61596.00 | 61219.00 | 61011.00 | 60143.00 |
還原基本每股稅後盈餘(元) | -0.73 | -0.83 | -0.73 | -0.82 | -0.75 | -0.81 | -0.72 | -0.73 | -0.55 | -2.35 |
還原稀釋每股稅後盈餘(元) | -0.74 | -0.83 | -0.73 | -0.82 | -0.75 | -0.81 | -0.72 | -0.73 | -0.54 | -2.35 |
還原基本平均股數(千股) | 68,592 | 67,974 | 66,876 | 66,261 | 63,684 | 63,059 | 61,596 | 61,219 | 61,011 | 60,143 |
還原稀釋平均股數(千股) | 68,592 | 67,974 | 66,876 | 66,261 | 63,684 | 63,059 | 61,596 | 61,219 | 61,011 | 60,143 |
EBITDA(千元) | -44,063 | -50,259 | -42,649 | -47,747 | -40,099 | -43,626 | -37,552 | -37,837 | -26,789 | -135,912 |